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ABSTRACT
Objectives Population-based HIV testing surveys have
become central to deriving estimates of national HIV
prevalence in sub-Saharan Africa. However, limited
participation in these surveys can lead to selection bias.
We control for selection bias in national HIV prevalence
estimates using a novel approach, which unlike
conventional imputation can account for selection on
unobserved factors.
Methods For 12 Demographic and Health Surveys
conducted from 2001 to 2009 (N=138 300), we predict
HIV status among those missing a valid HIV test with
Heckman-type selection models, which allow for
correlation between infection status and participation in
survey HIV testing. We compare these estimates with
conventional ones and introduce a simulation procedure
that incorporates regression model parameter uncertainty
into conﬁdence intervals.
Results Selection model point estimates of national HIV
prevalence were greater than unadjusted estimates for
10 of 12 surveys for men and 11 of 12 surveys for
women, and were also greater than the majority of
estimates obtained from conventional imputation, with
signiﬁcantly higher HIV prevalence estimates for men in
Cote d’Ivoire 2005, Mali 2006 and Zambia 2007.
Accounting for selective non-participation yielded 95%
conﬁdence intervals around HIV prevalence estimates
that are wider than those obtained with conventional
imputation by an average factor of 4.5.
Conclusions Our analysis indicates that national HIV
prevalence estimates for many countries in sub-Saharan
African are more uncertain than previously thought, and
may be underestimated in several cases, underscoring
the need for increasing participation in HIV surveys.
Heckman-type selection models should be included in
the set of tools used for routine estimation of HIV
prevalence.
INTRODUCTION
Accurate estimates of HIV prevalence are critical
for tracking the epidemic, designing and evaluating
prevention and treatment programmes, and esti-
mating resource needs.
1–6 In sub-Saharan Africa,
home to about two-thirds of the worldwide 33
million people living with HIV ,
1 national
population-based surveys
7–9 have become an essen-
tial data source for estimating HIV prevalence in
many countries.
10–12 A potential threat to the val-
idity of survey-based prevalence estimates is that
not all individuals eligible to participate in a
survey can be contacted, and some who are con-
tacted do not consent to HIV testing. Incomplete
participation in testing can lead to selection bias,
and a recent paper found evidence for substantial
downward bias in existing national HIV prevalence
estimates for Zambian men due to selective survey
non-participation.
13 The evaluation of possible
bias in HIV prevalence estimates for other coun-
tries in sub-Saharan Africa is thus important for
HIV research and policy.
Previous authors have suggested that non-
participation may lead to bias in HIV prevalence
estimates,
10 14 15 but ofﬁcial estimates of HIV
prevalence in sub-Saharan Africa rely heavily on
population-based surveys, which often have low
participation rates.
1 An analysis of the
Demographic and Health Surveys (DHS), which
are the most common nationally representative
surveys for HIV prevalence in sub-Saharan Africa,
reveals average rates of non-participation in HIV
testing of 23% for adult men and 16% for adult
women in the region, with a high of 37% for men
in Zimbabwe 2005–2006 and a low of 3% for
women in Rwanda 2005,
16 and the most recent
national population-based survey in South Africa
reported an overall non-participation rate of 32%
for HIV testing among adults.
7 Analyses of the
DHS have adjusted HIV prevalence estimates for
testing non-participation by imputing missing
HIV test results with probit regressions, control-
ling for differences in observed characteristics
between testing participants and non-participants,
such as gender, urban residence, wealth and indica-
tors of sexual behaviour, as recommended by
WHO.
16–18 Based on this conventional imputation
approach, non-participants were estimated to have
higher HIV prevalence than participants in about
half of the DHS examined, but this did not result
in substantially different estimates of overall HIV
prevalence when compared with the complete-case
estimates that ignored missing observations.
16
These results have been interpreted to mean that
non-participation in HIV testing surveys is likely
to have minimal impact on prevalence esti-
mates.
16 19 However, the conventional imputation
approach has two important limitations. First, it
assumes that no unobserved variables associated
with HIV status inﬂuence participation in HIV
testing. Second, it ignores regression parameter
uncertainty in the imputation model, resulting in
conﬁdence intervals (CI) that are too small.
The ﬁrst limitation of conventional imputation
is that non-participants are assumed to be ‘missing
at random’, implying that the expected HIV status
of non-participants is the same as that for
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20 However, if
any unobserved variable is correlated with testing and HIV
status, this condition will be violated. In particular, HIV status
itself may inﬂuence participation.
15 21 Individuals who know
that they are HIV-positive (because they have tested in the
past) may fear stigma, exclusion or abuse if others learn about
their HIV status.
22 23 Individuals who suspect that they are
HIV-positive (eg, based on past sexual behaviour) may fear con-
ﬁrmation of their suspicions.
24 The limited available empirical
evidence supports the hypothesis that HIV status correlates
with participation. A longitudinal study in Malawi showed
that among persons aware of a previous HIV test result those
who had tested HIV-positive were 4.6 times less likely to
consent to a new HIV test than those who had tested
HIV-negative.
15 In South Africa, a population-based, longitu-
dinal study found that HIV-positive individuals were substan-
tially less likely to consent to an HIV test than HIV-negative
individuals, and that among HIV-positive individuals those
who certainly knew their status were least likely to participate
in testing.
21
To address these issues, Bärnighausen et al
13 estimated HIV
prevalence in the Zambian 2007 DHS with a Heckman-type
selection model. This approach can control for correlation
between HIV status and HIV testing participation that remains
after selection on observed characteristics has been taken into
account. The national HIV prevalence estimate in adult
Zambian men was 21% after correcting for selection on unob-
served factors, compared with 12% in those with valid HIV
tests or based on conventional imputation.
This study aims to derive adjusted estimates of national HIV
prevalence in other sub-Saharan African countries using
Heckman-type selection models to correct for selective non-
participation in nationally representative surveys. It also
employs a novel method for computing 95% CI around
imputation-based HIV point estimates of prevalence that incor-
porates regression parameter uncertainty, which more accur-
ately reﬂects the additional uncertainty introduced when
imputing HIV status.
METHODS
Survey data
We examined data from 24 DHS (table 1).
25 A typical survey
involved a two-stage sampling design stratiﬁed by region and
urban versus rural setting.
25 26 Interviewing teams ﬁrst com-
pleted a 'household' questionnaire with one household member
to establish which household members were eligible for an
‘individual’ interview and for HIV testing. Members of the
interviewing team then elicited informed consent for HIV
testing from the eligible household members and conducted
the tests. A typical survey team included a team leader, a ﬁeld
editor and 3–6 interviewers who were usually matched to the
gender of eligible participants (table 1). In some surveys, health
professionals travelled with teams to conduct HIV testing,
while in others interviewers were trained to obtain consent and
blood samples (table 1).
Models to estimate HIV prevalence
We compared three strategies for handling missing HIV test
results when estimating HIV prevalence from DHS data, follow-
ing the analytic approach in Bärnighausen et al
13 and extending
it to improve the computation of CI. These models included: (1)
an unadjusted complete-case analysis in which missing observa-
tions are ignored and prevalence is calculated among those with
valid HIV tests, (2) a conventional imputation approach that
imputes missing HIV status conditional on observed covariates
using a probit regression and (3) a Heckman-type selection model
approach, which can correct for selection on unobserved factors
when imputing HIV status for missing observations. Eligible
individuals were missing valid HIV test results in the DHS for
two main reasons: (1) the individual was successfully contacted
but refused to consent to an HIV test or (2) the interview team
failed to contact or interview the individual. For both conven-
tional imputation and selection modelling approaches, we ran
separate regressions to predict missing HIV status in either the
‘non-consent’ or ‘non-contact’ groups.
Although uncommon in the biomedical literature, Heckman-
type selection models have been widely used for more than
3 decades in economics and other social sciences to estimate
regression coefﬁcients in the presence of missing data pro-
blems.
27 28 The selection model used in this analysis is a bivariate
probit regression comprised of a selection equation that predicts
HIV test participation and an outcome equation that predicts
HIV status, linked through a correlation parameter, ρ, that reﬂects
covariance between HIV status and testing participation, condi-
tional on observed covariates.
13 27 A negative estimate of
ρ implies that HIV-positive individuals were less likely to partici-
pate in HIV testing than HIV-negative individuals, all else being
equal, and in this case the model will predict higher probabilities
of being HIV-positive among non-participants. To improve the
identiﬁcation of the model, selection variables subject to an exclu-
sion restriction are included in the selection equation. The exclu-
sion restriction requires that the selection variables affect HIV
testing participation but are not correlated with HIV status. We
accounted for the complex survey design when estimating regres-
sion covariance matrices and used household sampling weights to
obtain national representative prevalence estimates (see online
technical appendix and reference 13 for details).
Selection variables
We used the same selection variables as Bärnighausen et al to
predict participation in HIV testing within Heckman-type
selection models.
13 For individuals who completed an individ-
ual interview but refused to consent to an HIV test (consent
regressions), the identity of the interviewer who conducted the
individual questionnaire was chosen as the selection variable
based on a long line of work in the survey sciences showing
that interviewer characteristics (eg, motivation, extraversion,
experience with HIV testing and attitudes about HIV research)
can inﬂuence consent to testing.
29–31 The DHS surveys in this
study varied in terms of which survey team members were
responsible for obtaining consent and blood samples for HIV
testing, which we have grouped into four categories (table 1).
25
For surveys that included interviewers who did not obtain
consent and conduct testing, these interviewers could affect
consent through their impact over the course of the lengthy
individual interview on respondents’ conﬁdence in the survey
process, or attitudes towards the survey team or participating
in HIV research.
For individuals who were eligible to participate but could not
be contacted or refused to be interviewed (contact regressions),
the identity of the interviewer who conducted the household
interview was chosen as one of two selection variables, as
these interviewers may differ in their ability to obtain informa-
tion on when the missing individual would return, in the fre-
quency of their follow-up visits or their ability to obtain
consent for the individual interview. We included a second
selection variable, indicating whether or not the household was
visited on the ﬁrst day that a team conducted interviews in a
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tunities to be revisited in the event an eligible member was
absent on the ﬁrst visit.
A key assumption of our approach is that the identity of the
survey interviewer and the day of the survey that a household
is ﬁrst visited correlate with testing but not with HIV status.
We tested the statistical signiﬁcance of the association between
the selection variables and HIV testing in each consent regres-
sion and each contact regression, separately by survey and sex,
using Wald tests with a two-sided p value of 0.05. It is highly
implausible that the identity of the interviewer in a DHS
survey could causally determine respondent HIV status at the
time of the interview,
29 and we controlled for observed factors
that were used to match interviewers to respondents, such as
region and urban setting, which could induce non-causal associ-
ation between interviewer identity and the HIV status of
potential survey participants.
Uncertainty estimation
Previous approaches to imputing HIV status for missing observa-
tions in the DHS have focused on sampling uncertainty condi-
tional on the estimated regression equations when calculating
standard errors (SE) or 95% CI for estimates of HIV preva-
lence.
13 16 17 This approach overstates the precision of
imputation-based HIV prevalence estimates because it ignores
estimation uncertainty about the imputation regression para-
meters. We incorporated this additional source of uncertainty
with a parametric simulation approach for the conventional
imputation and selection model-based imputation strategies.
32 33
The sampling distribution for predicted prevalence among those
without a valid HIV test was approximated by calculating preva-
lence from imputed HIV status for each of the 10 000 regression
parameter sets drawn from a multivariate normal distribution
parameterised by the maximum likelihood estimates for the
regression coefﬁcients and their covariance matrix. To obtain CI
for national prevalence estimates, the 10 000 draws from the sam-
pling distribution for imputed prevalence among non-participants
were combined with 10 000 draws for prevalence among those
with a valid HIV test, which were simulated from a binomial dis-
tribution deﬁned by the complete-case analysis. We induced cor-
relation between these two sets of prevalence values using a
copula method
34 with correlation coefﬁcients obtained from
bootstrapped prevalence estimates in a subset of surveys (further
details are described in the online technical appendix). We con-
ducted all statistical analyses in Stata V .11 (StataCorp, College
Station, Texas, USA) and prepared ﬁgures with R V .2.11.1
(R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Final survey sample
Our ﬁnal analysis included results from 12 of the 24 DHS
surveys that we examined (table 1) as the selection model
could not be used in several cases. DHS surveys for Mali 2001,
Democratic Republic of Congo 2007 and Zambia 2001–2002
were missing unique identiﬁers linking an individual’s question-
naire responses to their HIV test results or were missing an
Table 1 HIV testing strategies and personnel responsibilities in 24 Demographic and Health Surveys (DHS) as described in DHS survey reports,
2001–2009, with HIV testing participation rates for adult men and women.
HIV testing strategy and personnel
Pr.
HH*
No. of
teams
No. of
interviewers†
No. of
testers‡
% Participating§
Country Year Men Women
(1) Consent on individual questionnaire; interviewers
conducted HIV testing
Cote d’Ivoire 2005 1/1 10 2F, 2M – 76 79
Malawi 2004 1/3 22 4–5F, 1M (2–3) 63 70
Tanzania 2003–2004 1/1 11 4F, 1M – 77 84
Tanzania 2007–2008 1/1 14 4F, 1M – 80 90
Zimbabwe 2005–2006 1/1 14 3–4F, 2–3M – 63 76
(2) Consent on household questionnaire; interviewers
conducted HIV testing
Lesotho 2004 1/2 12 3F, 1M – 68 81
Liberia 2007 1/1 19 2F, 2M – 81 88
Sierra Leone 2008 1/2 24 2F, 1M – 87 90
Zambia 2007 1/1 12 3F, 3M – 72 77
(3) Consent on household questionnaire; subset of
interviewers conducted HIV testing
Cameroon 2004 1/2 14 3F, 1M (≥2) 90 92
Ethiopia 2005 1/2 30 4F, 2M (2) 76 83
Mali 2006 1/3 25 3 (2) 85 93
Niger 2006 1/2 20 3F, 1M (1) 84 91
Senegal 2005 1/3 15 3F, 1M (2) 75 84
Swaziland 2006–2007 1/1 10 3–4F, 1–2M ( 2 –3) 78 87
Rwanda 2005 1/2 15 3F, 1M (2) 96 97
(4) Consent on household questionnaire; health worker or
technician conducted HIV testing
Burkina Faso 2003 1/3 12 3F, 1M 1 86 92
Democratic Republic
of Congo
2007 1/2 234 1–3 1 86 90
Ghana 2003 1/2 15 4 1 80 89
Guinea 2005 1/2 10 4F, 1M 1 88 92
Kenya 2003 1/2 17 4F, 1M 1 70 76
Kenya¶ 2008–2009 1/2 23 4F, 2M 2 79 86
Mali 2001 1/3 25 3F 1 76 85
Zambia 2001 1/3 12 3–4F, 1M 2 73 79
*Proportion of sampled households that were eligible for HIV testing and the men’s individual questionnaire.
†Number of female and male interviewers per team. Team interviewer gender composition was not described in the reports for the Democratic Republic of Congo 2007, Mali 2006 and
Ghana 2003 surveys.
‡Number of individuals who conducted HIV testing per team. Numbers in parenthesis indicate the number of interviewers on a team who also conducted HIV testing. The symbol ‘–’
indicates that all interviewers conducted HIV testing.
§Percent participating in survey HIV testing.
¶Kenya 2008–2009 also had two voluntary counselling and testing counsellors on each team.
F, female; M, male; Pr. HH, Proportion of sampled households.
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lysed. Results for Burkina Faso 2003, Cameroon 2004, Guinea
2005, Kenya 2003, Kenya 2008–2009 and Sierra Leone 2008
were excluded because the estimate of the selection model cor-
relation parameter was near its boundary (|ρ|>0.9) in at least
one regression, indicating that model parameters were not well
identiﬁed. Models with |ρ|>0.9 also typically had highly sig-
niﬁcant p values. Last, the independent effects of region and
interviewer identity could not be estimated for Niger 2006,
Tanzania 2003–2004 and Tanzania 2007–2008 DHS.
Selection variables
Across 48 selection models (including separate regressions for
consent and contact, by sex and survey), interviewer identity
was signiﬁcantly associated with HIV testing participation (at
p<0.05), even after controlling for observed factors that were
used to match interviewers to respondents such as region and
urban setting, in 46 cases. The two exceptions were the
consent regression for men (p=0.07) and for women (p=0.16)
in Swaziland 2006–2007, see online supplementary table 1.
Among the 24 contact regressions, the coefﬁcient for the indi-
cator variable denoting whether or not a household was con-
tacted on the ﬁrst day that an interviewing team visited a
cluster was only signiﬁcantly associated with participation in
the Zambia 2007 women survey (see online supplementary
table 1).
Prevalence estimates
National estimates of adult HIV prevalence, by survey and separ-
ately for men and women, are depicted in ﬁgure 1 for the
complete-case, conventional imputation and Heckman-type
selection model approaches (see supplementary table 1 for more
detailed results). Selection model point estimates of national
HIV prevalence were greater than those based on a complete-
case analysis for 10 out of 12 surveys for men and 11 out of 12
surveys for women. In comparison with conventional imput-
ation, selection model point estimates were greater for eight of
12 surveys for men and 11 of 12 surveys for women. These dif-
ferences were statistically signiﬁcant in three surveys—Cote
d’Ivoire 2005, Mali 2006 and Zambia 2007—which had signiﬁ-
cant negative values for the selection model correlation param-
eter (ρ) in either the consent or contact regression for men,
indicating strong evidence of higher HIV prevalence among men
who did not participate in HIV testing. HIV prevalence esti-
mates derived from the selection modelling approach led to
changes in the sex ratio of HIV prevalence. As compared with
conventional imputation, the selection model estimated a lower
female-to-male prevalence ratio in seven surveys out of 12
surveys. However, the female-to-male prevalence ratio decreased
in ﬁve of the seven surveys that had substantial changes in HIV
prevalence point estimates, deﬁned as a greater than one per-
centage point change for either men or women (Cote d’Ivoire,
Mali, Swaziland, Zambia and Zimbabwe).
Allowing for the possibility that factors not measured in the
DHS may inﬂuence HIV testing participation resulted in much
greater uncertainty around prevalence estimates, with 95% CI for
HIV prevalence being 4.5 times wider on average for the selection
model estimates compared with those from conventional imput-
ation. On the other hand, in most cases, the 95% CI around the
selection model estimates were substantially tighter than the
most extreme bounds possible (see in ﬁgure 1), which are derived
by assuming that all non-participants were uniformly either
HIV-negative (for the lower bound) or HIV-positive (for the
upper bound). Incorporating regression parameter uncertainty led
to 95% CI that were 1.2 times larger for the conventional imput-
ation estimates and 4.9 times larger for the selection model esti-
mates, as compared with the CI obtained for those same models
when only sampling uncertainty was accounted for and regres-
sion parameter uncertainty was ignored.
Sensitivity analyses
Sensitivity analyses of two key assumptions of the bivariate
probit selection model used in this analysis suggested that our
ﬁndings were relatively robust to deviations from key model
assumptions. First, a simulation experiment based on the
Zambia 2007 DHS, which assessed the sensitivity of the selec-
tion model to violations of its assumption that interviewer
effects on participation do not vary with respect to respondent
HIV status, indicated that the large adjustment to the HIV
prevalence estimate for men could not be explained by a viola-
tion of this assumption. Second, estimates of the correlation
parameter ρ from a semi-non-parametric selection model
(which relaxes the assumption of bivariate normality of the
error terms
35) were modestly correlated with those from the
parametric model. A full description of these analyses can be
found in the online technical appendix.
DISCUSSION
Heckman-type selection models offer a means of testing and
correcting for sample selection in HIV testing surveys. We
investigated the applicability of one variant of this type of
selection model, which uses the identity of survey interviewer
and the timing of the interview, to DHS datasets from
sub-Saharan Africa. We could not apply this approach in half
the data sets we examined either because data on the selection
variables were missing or the models could not be identiﬁed.
Our analysis of the 12 DHS for which we could apply the
approach indicated that the relationship between HIV status
and participation in HIV testing may vary across surveys, but
likely leads to underestimates of prevalence in several countries.
Additionally, ignoring selection on unobserved factors with
conventional imputation approaches substantially overstates
the precision of HIV prevalence estimates in many sub-Saharan
African countries.
Among the ﬁnal sample of 12 surveys, the Heckman-type
selection model results can be viewed as a sensitivity analysis
of conventional HIV prevalence estimates.
36 The selection
model estimates agree with, and add credibility to, existing
prevalence estimates for countries such as Liberia, Rwanda and
Senegal. However, on average the selection model estimates had
CI that were 4.5 times larger than those from conventional
imputation, indicating that we are unable to precisely estimate
the effect that bias due to low participation rates may have on
HIV prevalence estimates in many surveys. Thus, for many
countries, including those in southern Africa, policy makers
should consider using a wider range of potential values when
making decisions that depend on national levels of HIV preva-
lence. Last, selection model estimates resulting in signiﬁcant,
large increases in estimated HIV prevalence among men in
Cote d’Ivoire, Mali and Zambia are most concerning and
suggest that renewed focus on HIV prevention in men would
be particularly justiﬁed in these countries.
37
The narrow CI frequently reported around conventional esti-
mates of national HIV prevalence reﬂect a false precision result-
ing from the assumption that testing non-participants are
‘missing at random’.
16 17 The selection model approach relaxes
this assumption as it does not assume that the correlation par-
ameter ρ equals 0 with certainty; the wider CI around selection
i20 Sex Transm Infect 2012;88:i17–i23. doi:10.1136/sextrans-2012-050636
Supplementmodel-based estimates reﬂect uncertainty about the strength of
the relationship between HIV status and testing. These results
offer a quantiﬁcation of uncertainty around values for popula-
tion HIV prevalence that is more conservative yet more accurate
than conventional approaches
16 17 and typically much narrower
than an extreme bounds approach (ﬁgure 1). The CI estimated
using our approach are also more interpretable from a sampling
theory perspective than sensitivity analyses that apply ﬁxed
factors to existing estimates.
14 15
Underestimating the uncertainty around HIV prevalence esti-
mates derived from national population-based surveys has
important implications, as it will impact the weight placed on
other sources of HIV surveillance data and overstate the preci-
sion of measures of HIV burden used in global and national
HIV policymaking. For example, in its recent report on the
global epidemic, the United Nations Joint Programme of HIV/
AIDS (UNAIDS) estimates HIV prevalence in sub-Saharan
Africa by rescaling models ﬁt to antenatal clinic (ANC) data so
that they are compatible with population-based survey
estimates for prevalence.
13 8If there is less certainty about
estimates from population-based surveys than previously
thought, weighing ANC data more heavily in such analyses
may be appropriate. This would also have implications for esti-
mating HIV incidence, which can be derived from the epidemic
models used by UNAIDS
39 or estimated from changes in HIV
prevalence between two population-based surveys.
40
Adjustments of HIV prevalence estimates will also affect indi-
cators of antiretroviral treatment coverage,
1 for instance, as
measured by the US President’s Emergency Plan for AIDS
Relief programme
41 and model-based predictions of future HIV
trends.
39
Our study has several limitations. For surveys in which
health workers or technicians obtained HIV test consent and
blood samples (table 1, category 4), we could only control for
the identities of interviewers in the selection model. Although
interviewer identity was a signiﬁcant predictor of HIV testing
participation in all except one of these ﬁve surveys, the major-
ity of them had selection models with estimates of ρ near the
boundary for at least one group, suggesting model identiﬁcation
problems. Future surveys should record the identities of the
individuals responsible for conducting HIV testing, in addition
to interviewer identity, to allow for broader applicability of
selection models. Bayesian methods that enable the estimation
of selection model parameters in cases like Tanzania where
maximum likelihood techniques fail to converge may also
enable wider application of these methods.
Heckman-type selection models can be sensitive to violations
of model assumptions,
28 and methodological work is needed to
Figure 1 National adult HIV
prevalence estimates with 95% CI
derived from three modelling
approaches for men and women from
12 Demographic and Health Surveys
conducted in sub-Saharan Africa,
2001–2009. Women aged 15–49 years
were eligible to be tested for HIV. The
age range for men was 15–59 years,
with the exceptions of Cote d’Ivoire,
Liberia and Swaziland (15–49 years)
and Malawi and Zimbabwe
(15–54 years). HIV infection was
deﬁned as infection with either HIV-1
or HIV-2. Apart from the selection
variables described in the text, all
other covariates were shared by the
two model components of the
selection models and the conventional
imputation probit regressions. For
‘consent’ regressions, these variables
were: age, educational attainment,
household wealth quintile as
constructed from an index of
household assets, urban setting,
region, interview language, ethnicity,
religion, marital status, high-risk sexual
behaviour in the past year, condom
use at last sex, sexually transmitted
disease in the past year, tobacco and
alcohol use, knowing someone with
AIDS, willingness to care for a family
member with AIDS, and having had a
previous HIV test. For ‘contact’
regressions, these variables were: sex,
age, education, wealth quintile, urban
setting and region (see details in online
technical appendix). ‘Extreme bounds’
assume that all those missing a valid
HIV test are uniformly HIV-positive or
HIV-negative.
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researchers. The selection model implemented here assumes
that the error terms for the selection and outcome equations
are distributed bivariate normal, and therefore relies on para-
metric assumptions for extrapolation. The plausibility of this
assumption can be tested with semi- or non-parametric selec-
tion models.
42 In an initial sensitivity analysis, we found a
modest correlation between estimates for ρ obtained from a
semi-non-parametric model and the parametric model used in
our main analysis. However, as explained in the online tech-
nical appendix, further development of these methods is
needed to establish strong tests of assumption validity.
The choice of selection variables can also impact selection
model estimates,
28 but we only identiﬁed one variable that
consistently predicted HIV testing. Our use of interviewer
identity as a selection variable has a behavioural justiﬁca-
tion
29 and has been used in at least three previous
studies employing Heckman-type selection models of HIV in
Africa.
13 43 44 It is unlikely that interviewers could affect
respondent HIV status, and we controlled for the variables
used to match interviewers with respondents, namely region
and sex. In simulations consistent with the Zambia 2007
data, we found that violations of this assumption would be
unlikely to explain the large adjustment to prevalence esti-
mated for adult men in Zambia.
Ideally, the validity and precision of HIV prevalence esti-
mates could be improved through increased HIV testing partici-
pation. Increasing contact rates could be achieved through
renewed emphasis on revisiting households to test absent
members or encouraging individuals who are unwilling to com-
plete the questionnaire to participate in HIV testing. Improving
consent rates may be possible if an oral swab is used instead of
collecting blood
45 46 and approaches such as ﬁnancial incen-
tives,
47 48 resampling previous refusers or offering test results
and referral to care could be investigated. A deeper understand-
ing of what characteristics predict an individual’s propensity to
test, and how they relate to HIV status, would be useful, and
more research on methods for improving HIV testing participa-
tion during large-scale surveys is needed.
In the absence of increased HIV testing participation, we rec-
ommend that Heckman-type selection models be included
among the toolkit of routine analyses when estimating HIV
prevalence, deriving epidemic indicators from HIV prevalence
or modelling the determinants of HIV status, as a check on the
robustness of conventional methods. To facilitate these efforts,
survey reports should describe interview team composition and
include unique identiﬁers for those responsible for contacting
households, obtaining consent and conducting HIV tests.
Common software packages implement the bivariate probit
model, including Stata, SAS and R. We also suggest that ana-
lysts incorporate parameter uncertainty when calculating CI
around imputation-based estimates. We used a parametric
simulation approach to do this;
32 the bootstrap and Bayesian
algorithms could be useful alternatives in other settings.
49 50
In conclusion, Heckman-type selection models provide a useful
addition to the set of tools used for the estimation of HIV preva-
lence from national surveys. In settings where they can be identi-
ﬁed, selection models offer a means of assessing potential
problems with conventional estimates of HIV prevalence and
may suggest substantially revised estimates in some cases. Our
analysis indicates that national HIV prevalence estimates for
many countries in sub-Saharan Africa are more uncertain than
previously thought, and may be underestimated in several cases.
This suggests that more emphasis should be put on increasing
participation in HIV testing in surveys that aim to establish
national prevalence rates.
Key messages
▸ National population-based surveys that include HIV testing
are a critical source of evidence on HIV prevalence in
sub-Saharan Africa.
▸ Selection models can be used to correct HIV prevalence
estimates derived from these surveys for selection bias due
to non-participation in HIV testing.
▸ This study suggests that important uncertainty remains
around estimates of HIV prevalence in sub-Saharan Africa
and that HIV prevalence may be underestimated in several
countries.
▸ More emphasis should be placed on increasing participation
in HIV surveys.
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